$EPAZ CapitalGainsReport: Riding the Rebound: Boun
Post# of 103062
(Total Views: 69)
Posted On: 05/16/2023 9:05:49 AM
$EPAZ CapitalGainsReport: Riding the Rebound: Bounce Watchlist (EPAZ, ENZC, DPLS, SEII)
05/16/2023 | 01:58am EDT
While the week may have begun with a downward trajectory for these four stocks, their current performance should not overshadow their potential for a swift recovery. In fact, they possess the attributes that could propel them back into the realm of growth and profitability. Let's explore these stocks in more detail and uncover the factors that make them worthy contenders for a rebound.
Despite a slow start this week, these four stocks have the potential to bounce back and regain their momentum. Let's delve into their details and discover why they could be prime candidates for a strong recovery.
Epazz Inc. (OTC: EPAZ) remains at the forefront of the drone technology market, captivating both investors and industry experts with its groundbreaking advancements. As a company renowned for its mission-critical solutions encompassing drone technology, blockchain mobile apps, and cloud-based business software, EPAZ continues to make significant strides.
EPAZ's stock price has shown resilience, surging by 20.00% over the past five days, reaching 0072 USD. This consistent performance, despite a minor dip on Monday, reflects the growing confidence of investors in the company's advancements and potential.
The company's commitment to innovation is evident through its active pursuit of AI patents for drone technology. With two patents already granted and two others under review, EPAZ solidifies its position as a pioneering force in the industry. Moreover, EPAZ has filed international patents to expand its global presence and protect its intellectual property rights.
ZenaDrone Inc., EPAZ's subsidiary, is actively expanding its facilities in Dubai, UAE, to meet the surging demand for its drone technology. This strategic move allows ZenaDrone to enhance production capabilities and effectively cater to evolving customer needs across various industries. Notably, the U.S. Air Force has recognized EPAZ's drone technology and is exploring its potential in cargo delivery. As a result, ZenaDrone has been invited to conduct tests under battlefield conditions at an overseas base, further validating the technological capabilities and impact of EPAZ's drone solutions.
Investor interest in EPAZ remains high, as evidenced by the company's stock price, which has increased by 30.43% in the last five days. This sustained growth reflects market confidence in EPAZ's innovative developments and its potential for future success.
EPAZ's dedication to innovation extends to its pursuit of AI patents for drone technology, ensuring exclusivity for its cutting-edge solutions. The company's global presence is further fortified through international patent filings, solidifying its dominance in key regions worldwide.
ZenaDrone Inc. is expanding its operations in Dubai, UAE, in response to rising demand for its drone technology. This growth demonstrates EPAZ's dedication to providing dependable and high-quality drone solutions on a global scale.
Recognition from the U.S. Air Force highlights EPAZ's position as a trusted provider of advanced drone technology. The military's exploration of EPAZ's drone technology for cargo delivery applications further demonstrates its potential impact in critical scenarios.
EPAZ's focus on the commercial drone market is evident through recent developments, such as the visit by Ossian Smyth, the Minister of State at the Department of Public Expenditure and Reform of Ireland. The visit aimed to explore the transformative potential of ZenaDrone's technology across various sectors, including agriculture, businesses, and government agencies.
Currently, EPAZ is in negotiations with a financing institution to acquire up to 100 ZenaDrone 1000s, their flagship drone, for drone-as-a-service operations in Ireland. This non-dilutive financing opportunity aims to establish drones-as-a-service operations, providing advanced precision agriculture drones to Irish farmers, businesses, and government agencies for tasks like plant health monitoring and weed spraying.
EPAZ continues to achieve remarkable milestones, positioning itself as a leader in drone technology solutions. With its cutting-edge products and dedication to innovation, the company is poised to shape the future and establish a strong presence in the global market.
Enzolytics, Inc. (OTC: ENZC) is a drug development company specializing in proprietary proteins and monoclonal antibodies for treating infectious diseases. Despite recent price fluctuations, with a decrease in the past few days, ENZC has shown an overall positive trend over the last month, with a significant increase of 79.10%.
ENZC's key compound is called ITV-1, which has been tested as a treatment for HIV/AIDS and has immune system modulation capabilities. They also utilize their proprietary technology to produce fully human monoclonal antibodies (mAbs) that target infectious diseases, including COVID-19, HIV-1, and feline leukemia.
A pilot clinical trial of ITV-1 is being conducted at the Bulgarian National Center for Endocrinology to assess its efficacy in the treatment of diabetes. ENZC subsidiary VIRO has purchased a flow machine for standardized industrial production of ITV-1. By late fall, the company hopes to see the first effects of giving ITV-1 to HIV patients.
The European Medicine Agency (EMA) and ENZC are working closely together to register ITV-1 in Europe.
In addition to drug development, ENZC's nutraceutical product, IPF Immune, has seen tremendous success in the U.S. market, quickly selling out and receiving positive user testimonials. The company is now registering IPF Immune in various European countries, including Spain, Germany, Romania, Greece, and Bulgaria.
ENZC is also planning to submit applications to the FDA for two new nutraceutical products: brain detoxification and liver detoxification supplements.
Overall, ENZC's stock has shown resilience and potential with its infectious disease therapeutics and expanding product lines. Despite recent fluctuations, the company remains focused on delivering innovative solutions and pursuing regulatory approvals to drive future growth
DarkPulse, Inc. (OTC: DPLS) specializes in laser-based monitoring systems for structural integrity, making significant contributions to the advancement of smart cities.
DarkPulse's stock closed down just 2.17% from its opening price. This performance could be attributed to the company's recent filing delay. DarkPulse filed a Form 12b-25 with the SEC to indicate a delay in filing their Form 10-Q for the fiscal year ended March 31, 2023. The company was unable to complete the review process with the auditor, according to the filing.
Despite today's dip, DarkPulse's stock has shown notable performance over the past five days. It has witnessed a steady increase, gaining 12.50% over the time period. This positive trend could demonstrate the market's recognition of DarkPulse's structural monitoring laser technology and the potential impact it could have on smart cities' development.
Sharing Economy International Inc. (OTC: SEII) has some bounce potential in the e-mobility sector. SEII has recently shifted its focus to capitalize on the growing market for zero-emission electric and hydrogen vehicles.
The company's engagement with BIP Consulting, a reputable business consulting group, highlights their commitment to establishing joint ventures with leading automobile manufacturers to develop and distribute electric trucks for rental purposes.
Despite recent fluctuations in stock performance, SEII's current stock price of $0.0013 USD per share indicates the potential for a bounce. With a notable decrease of -38.10% today, the stock has experienced a significant pullback. However, it is important to note that over the past five days, SEII witnessed a positive increase of 30.00%. These price dynamics suggest that SEII could be primed for a potential bounce.
Investors interested in stocks with bounce potential may find SEII worth considering. The company's strategic focus on zero-emission electric and hydrogen vehicles aligns with the growing global demand for sustainable transportation solutions.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.
CONTACT: CapitalGainsReport
Mark McKelvie
Editor
Markrmckelvie@gmail.com
585-301-7700
https://www.marketscreener.com/quote/stock/EP...er-partage
05/16/2023 | 01:58am EDT
While the week may have begun with a downward trajectory for these four stocks, their current performance should not overshadow their potential for a swift recovery. In fact, they possess the attributes that could propel them back into the realm of growth and profitability. Let's explore these stocks in more detail and uncover the factors that make them worthy contenders for a rebound.
Despite a slow start this week, these four stocks have the potential to bounce back and regain their momentum. Let's delve into their details and discover why they could be prime candidates for a strong recovery.
Epazz Inc. (OTC: EPAZ) remains at the forefront of the drone technology market, captivating both investors and industry experts with its groundbreaking advancements. As a company renowned for its mission-critical solutions encompassing drone technology, blockchain mobile apps, and cloud-based business software, EPAZ continues to make significant strides.
EPAZ's stock price has shown resilience, surging by 20.00% over the past five days, reaching 0072 USD. This consistent performance, despite a minor dip on Monday, reflects the growing confidence of investors in the company's advancements and potential.
The company's commitment to innovation is evident through its active pursuit of AI patents for drone technology. With two patents already granted and two others under review, EPAZ solidifies its position as a pioneering force in the industry. Moreover, EPAZ has filed international patents to expand its global presence and protect its intellectual property rights.
ZenaDrone Inc., EPAZ's subsidiary, is actively expanding its facilities in Dubai, UAE, to meet the surging demand for its drone technology. This strategic move allows ZenaDrone to enhance production capabilities and effectively cater to evolving customer needs across various industries. Notably, the U.S. Air Force has recognized EPAZ's drone technology and is exploring its potential in cargo delivery. As a result, ZenaDrone has been invited to conduct tests under battlefield conditions at an overseas base, further validating the technological capabilities and impact of EPAZ's drone solutions.
Investor interest in EPAZ remains high, as evidenced by the company's stock price, which has increased by 30.43% in the last five days. This sustained growth reflects market confidence in EPAZ's innovative developments and its potential for future success.
EPAZ's dedication to innovation extends to its pursuit of AI patents for drone technology, ensuring exclusivity for its cutting-edge solutions. The company's global presence is further fortified through international patent filings, solidifying its dominance in key regions worldwide.
ZenaDrone Inc. is expanding its operations in Dubai, UAE, in response to rising demand for its drone technology. This growth demonstrates EPAZ's dedication to providing dependable and high-quality drone solutions on a global scale.
Recognition from the U.S. Air Force highlights EPAZ's position as a trusted provider of advanced drone technology. The military's exploration of EPAZ's drone technology for cargo delivery applications further demonstrates its potential impact in critical scenarios.
EPAZ's focus on the commercial drone market is evident through recent developments, such as the visit by Ossian Smyth, the Minister of State at the Department of Public Expenditure and Reform of Ireland. The visit aimed to explore the transformative potential of ZenaDrone's technology across various sectors, including agriculture, businesses, and government agencies.
Currently, EPAZ is in negotiations with a financing institution to acquire up to 100 ZenaDrone 1000s, their flagship drone, for drone-as-a-service operations in Ireland. This non-dilutive financing opportunity aims to establish drones-as-a-service operations, providing advanced precision agriculture drones to Irish farmers, businesses, and government agencies for tasks like plant health monitoring and weed spraying.
EPAZ continues to achieve remarkable milestones, positioning itself as a leader in drone technology solutions. With its cutting-edge products and dedication to innovation, the company is poised to shape the future and establish a strong presence in the global market.
Enzolytics, Inc. (OTC: ENZC) is a drug development company specializing in proprietary proteins and monoclonal antibodies for treating infectious diseases. Despite recent price fluctuations, with a decrease in the past few days, ENZC has shown an overall positive trend over the last month, with a significant increase of 79.10%.
ENZC's key compound is called ITV-1, which has been tested as a treatment for HIV/AIDS and has immune system modulation capabilities. They also utilize their proprietary technology to produce fully human monoclonal antibodies (mAbs) that target infectious diseases, including COVID-19, HIV-1, and feline leukemia.
A pilot clinical trial of ITV-1 is being conducted at the Bulgarian National Center for Endocrinology to assess its efficacy in the treatment of diabetes. ENZC subsidiary VIRO has purchased a flow machine for standardized industrial production of ITV-1. By late fall, the company hopes to see the first effects of giving ITV-1 to HIV patients.
The European Medicine Agency (EMA) and ENZC are working closely together to register ITV-1 in Europe.
In addition to drug development, ENZC's nutraceutical product, IPF Immune, has seen tremendous success in the U.S. market, quickly selling out and receiving positive user testimonials. The company is now registering IPF Immune in various European countries, including Spain, Germany, Romania, Greece, and Bulgaria.
ENZC is also planning to submit applications to the FDA for two new nutraceutical products: brain detoxification and liver detoxification supplements.
Overall, ENZC's stock has shown resilience and potential with its infectious disease therapeutics and expanding product lines. Despite recent fluctuations, the company remains focused on delivering innovative solutions and pursuing regulatory approvals to drive future growth
DarkPulse, Inc. (OTC: DPLS) specializes in laser-based monitoring systems for structural integrity, making significant contributions to the advancement of smart cities.
DarkPulse's stock closed down just 2.17% from its opening price. This performance could be attributed to the company's recent filing delay. DarkPulse filed a Form 12b-25 with the SEC to indicate a delay in filing their Form 10-Q for the fiscal year ended March 31, 2023. The company was unable to complete the review process with the auditor, according to the filing.
Despite today's dip, DarkPulse's stock has shown notable performance over the past five days. It has witnessed a steady increase, gaining 12.50% over the time period. This positive trend could demonstrate the market's recognition of DarkPulse's structural monitoring laser technology and the potential impact it could have on smart cities' development.
Sharing Economy International Inc. (OTC: SEII) has some bounce potential in the e-mobility sector. SEII has recently shifted its focus to capitalize on the growing market for zero-emission electric and hydrogen vehicles.
The company's engagement with BIP Consulting, a reputable business consulting group, highlights their commitment to establishing joint ventures with leading automobile manufacturers to develop and distribute electric trucks for rental purposes.
Despite recent fluctuations in stock performance, SEII's current stock price of $0.0013 USD per share indicates the potential for a bounce. With a notable decrease of -38.10% today, the stock has experienced a significant pullback. However, it is important to note that over the past five days, SEII witnessed a positive increase of 30.00%. These price dynamics suggest that SEII could be primed for a potential bounce.
Investors interested in stocks with bounce potential may find SEII worth considering. The company's strategic focus on zero-emission electric and hydrogen vehicles aligns with the growing global demand for sustainable transportation solutions.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.
CONTACT: CapitalGainsReport
Mark McKelvie
Editor
Markrmckelvie@gmail.com
585-301-7700
https://www.marketscreener.com/quote/stock/EP...er-partage
(0)
(0)
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
Scroll down for more posts ▼